Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ).
Recordati S.p.A. has updated on its share buyback program, initiated to support stock option and incentive plans for its management. Between February 10 to 14, 2025, the company purchased 52,980 shares, enhancing its hold to 1.203% of the share capital, which could potentially strengthen its market position and stakeholder confidence.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group originating from Italy, offering therapeutic options in specialty drugs, general medicine, and rare diseases. With its roots in a family pharmacy from the 1920s, the company now operates globally across 150 countries with over 4,450 employees, integrating clinical development, production, marketing, and licensing.
YTD Price Performance: 18.38%
Average Trading Volume: 25,893
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €12.36B
For a thorough assessment of REC stock, go to TipRanks’ Stock Analysis page.
